Current Advances of Nanomedicines Delivering Arsenic Trioxide for Enhanced Tumor Therapy

Arsenic trioxide (ATO) is one of the first-line chemotherapeutic drugs for acute promyelocytic leukemia. Its anti-cancer activities against various human neoplastic diseases have been extensively studied. However, the clinical use of ATO for solid tumors is limited, and these limitations are because...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Mengzhen Yu, Yanwen Zhang, Meirong Fang, Shah Jehan, Wenhu Zhou
Médium: Artigo
Jazyk:Inglês
Vydáno: MDPI AG 2022-03-01
Edice:Pharmaceutics
Témata:
Arsenic trioxide
nanomedicines
bioavailability
cytotoxicity
synergistic effect
combinatorial treatment
On-line přístup:https://www.mdpi.com/1999-4923/14/4/743
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky